about
The analysis of survival data with a non-susceptible fraction and dual censoring mechanisms.Blood pressure and survival in the oldest old.Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital systemUsing cancer registry data for recruitment of sexual minority women: successes and limitations.Association between mental health conditions and rehospitalization, mortality, and functional outcomes in patients with stroke following inpatient rehabilitation.Developing a quality measure for clinical inertia in diabetes care.Effects of daily adherence to antihypertensive medication on blood pressure controlUse of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleedingBasic Bayesian methods.Regional variation in intervention rates: what are the implications for patient selection?Gender differences in combat-related stressors and their association with postdeployment mental health in a nationally representative sample of U.S. OEF/OIF veterans.Health-related quality of life in breast cancer survivors of different sexual orientations.An examination of cross-specialty linkage applied to the resource-based relative value scale.Comparing sexual minority cancer survivors recruited through a cancer registry to convenience methods of recruitment.Breast cancer survivors of different sexual orientations: which factors explain survivors' quality of life and adjustment?The incremental value of self-reported mental health measures in predicting functional outcomes of veterans.Psychometric properties of the Spanish BASIS-24 mental health survey.Mental and physical health status and alcohol and drug use following return from deployment to Iraq or Afghanistan.Improving risk adjustment of self-reported mental health outcomes.Stopping rules for surveys with multiple waves of nonrespondent follow-up.Sex differences in intellectual performance: analysis of a large cohort of competitive chess players.Functional status outcomes among white and African-American cardiac patients in an equal access system.Modeling the effects of genetic factors on late-onset diseases in cohort studies.Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients. Results from the Cooperative Cardiovascular Project.Hypertension Management in Patients With Diabetes: The need for more aggressive therapyInadequate Management of Blood Pressure in a Hypertensive PopulationApo-E genotypes and cardiovascular diseases: a sensitivity study using cross-validatory criteriaThe effect of age on hypertension control and management
P50
Q30881322-4923AAE4-F17A-4927-A123-5A84671FC57CQ33277116-6EF118B1-D81E-4FCF-B580-3252148C7D9AQ33523160-AC3E77B5-1A45-4A96-9A82-9BD4AB30CC23Q33615085-4ECB6E12-B8A8-4DB9-976D-4EA33CC15095Q34074991-0E72060C-6DE5-4BA9-A817-DA31E6F79226Q34337783-7D7C1E4D-1235-42BC-B71B-520EAAEB5149Q35037085-66FE566D-7E49-48D9-8405-35E04C4D98FEQ36972556-4F1983C5-A446-4073-9D02-006C15CAC32DQ37152118-734FDB9F-9B32-4F9E-8F08-80CA390249C3Q38910838-AA19FDF9-B74C-47EE-BBCC-F32DCB5B9909Q39288202-3466F0DA-9FBD-4663-9DE7-B9A9065D457FQ39740790-D2D90DB2-D321-46FF-B77B-73196A358C5EQ41575219-5B9727B8-2808-41B5-B932-1F72AB68EFB0Q42606626-84FF9BD0-016B-4FB7-8BD4-A9CE62179325Q44009904-3A266AE1-965C-43ED-877A-1569900927D8Q45330829-901277FC-35A9-4805-AAE6-45648C0B432AQ45990484-2F2B52BD-0F8C-4BCD-88E6-D7A502815036Q51756616-DEFEF9E4-B01D-411F-93E5-EC4C5EBBCBB6Q51861526-4909B982-519F-44FB-8393-E8C7D30BF0C6Q51905453-3BBAD1AC-058A-43B6-90AF-0C91FD2F77C6Q51908301-8EDC4C24-B761-4559-9B13-CBB1AC425A9CQ51922064-490965EC-2B66-40A0-9073-F728EC2C27BDQ52034585-F3E8FF02-DA89-4597-BA74-60B971D17133Q52201930-DC327863-2772-4923-9115-BEB019B15DC7Q61822156-32C77BC2-B479-4643-AC8C-756086120456Q61822162-CAC3BB56-3E75-4E75-9385-3D132B4A1161Q81213396-60965692-8C90-4A98-8F72-DD2D433B0FC6Q83220418-0D499576-07E3-4595-AA99-399D8CCA1274
P50
description
American researcher
@en
US-Amerikanischer Wissenschaftler
@de
wetenschapper
@nl
name
Mark E Glickman
@sl
Mark E. Glickman
@de
Mark E. Glickman
@en
Mark E. Glickman
@es
Mark E. Glickman
@fr
Mark E. Glickman
@it
Mark E. Glickman
@nl
type
label
Mark E Glickman
@sl
Mark E. Glickman
@de
Mark E. Glickman
@en
Mark E. Glickman
@es
Mark E. Glickman
@fr
Mark E. Glickman
@it
Mark E. Glickman
@nl
altLabel
Mark Glickman
@en
prefLabel
Mark E Glickman
@sl
Mark E. Glickman
@de
Mark E. Glickman
@en
Mark E. Glickman
@es
Mark E. Glickman
@fr
Mark E. Glickman
@it
Mark E. Glickman
@nl
P106
P21
P31
P496
0000-0003-3993-2801
P569
2000-01-01T00:00:00Z